Cholangiocarcinoma Foundation's Calendar of Events
unless otherwise stated, all times are in Eastern Time, UTC -4.
Week of Jul 18th
July 22, 2021 (1 event)
Webinar: An interesting new study at NCI: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Biliary Tract Carcinoma
–
July 22, 2021CCF Webinar Series
An interesting new study at NCI: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Biliary Tract Carcinoma
Thursday, July 22, 2021, at 4:00pm (EDT)Presented by: Cecilia Monge, M.D., M.P.H., FACP.
Dr. Cecilia Monge specializes in first-in-human and early-phase clinical studies of gastrointestinal (GI) malignancies, including liver cancer, biliary tract cancer, colorectal cancer and pancreatic cancer.
Join us to learn about a new clinical trial at the National Cancer Institute.
